Daily low dose aspirin increases brain bleeding risk by 38% in older adults.
Daily low dose aspirin increases brain bleeding risk by 38% in older adults.
The Effects of Low Dose Aspirin on Stroke Risk in Older Adults
Image Source: Tim Boyle/Getty Images
In a recent study, researchers have discovered that while low dose aspirin may have some benefits in reducing stroke risk, it also poses potential risks for older adults, especially in terms of intracranial bleeding. This finding challenges the commonly held belief that taking a daily dose of aspirin is an effective preventive measure against stroke. It emphasizes the importance of considering individual risk factors before prescribing aspirin.
Understanding Stroke and its Impact
Stroke occurs when blood is either blocked from entering the brain (ischemic stroke) or when there is sudden bleeding in the brain (hemorrhagic stroke). In the United States alone, over 795,000 people suffer from a stroke each year, and approximately 1 in 6 deaths related to cardiovascular conditions can be attributed to stroke. Preventive strategies are crucial for reducing the incidence of this debilitating condition.
For years, aspirin has been widely used as a common pain medication to prevent stroke. While meta-analyses have indicated that low dose aspirin may help reduce the risk of stroke, clinical trials have also shown that it can increase the chances of intracranial and intracerebral hemorrhages (bleeding in the skull and brain).
The Complexity of Stroke Prevention in Older Adults
It is important to note that older individuals are particularly vulnerable to hemorrhages due to the fragility of their small blood vessels and increased risk of trauma from falls and accidents. These factors can affect the overall risks and benefits of using aspirin as a preventive measure in this population. In order to develop effective stroke prevention strategies, it is vital to understand how low dose aspirin impacts stroke and hemorrhage risk in older adults.
- Vaping may be more effective than nicotine patches for pregnant wom...
- Different types of gender identity?
- Fertile days for pregnancy?
A recent study published in JAMA Geriatrics aimed to investigate the effects of low dose aspirin on stroke and hemorrhage risk in older adults. The study analyzed data from 19,114 participants with an average age of 74 years. None of the participants had a history of cardiovascular conditions such as stroke, atrial fibrillation (AFib), or heart attack.
The participants were randomly assigned to one of two groups: one group received a daily 100 mg dose of aspirin, while the other group received a placebo. The participants were then monitored for an average of 4.7 years.
Study Findings and Insights
The researchers discovered that low dose aspirin did not significantly reduce the risk of stroke. However, they did find that it increased the risk of intracranial bleeding by 38%.
Specifically, the study revealed that 1.5% of those assigned to aspirin (146 individuals) experienced a stroke, while 1.7% of those in the placebo group (166 individuals) had a stroke. Similarly, aspirin did not lead to statistically significant reductions in hemorrhagic strokes, as 0.5% of aspirin participants (49 individuals) and 0.4% of placebo participants (37 individuals) experienced this type of stroke. Moreover, individuals taking aspirin were significantly more likely to develop intracranial bleeding compared to those taking a placebo, with incidence rates of 1.1% and 0.8%, respectively.
Dr. Arun Manmadhan, assistant professor of medicine at Columbia University, commenting on the study, highlighted that routine use of aspirin for preventing first-time cardiovascular events in the general adult population seems to provide limited benefit and may even cause harm due to excess bleeding. These findings align with the U.S. Preventive Services Task Force recommendations that advise against routine aspirin use for cardiovascular disease prevention in adults over the age of 60.
Unraveling the Mechanisms Behind Aspirin’s Impact
It is important to understand how aspirin affects stroke risk in order to comprehend its potential benefits and risks. According to Dr. Hardik P. Amin, associate professor of neurology at Yale School of Medicine, aspirin functions as a blood thinner by preventing platelets, the blood cells responsible for clotting, from forming clumps inside blood vessels. By doing so, it lowers the risk of heart attacks and strokes.
However, Dr. Walavan Sivakumar, a board-certified neurosurgeon and director of neurosurgery at Pacific Neuroscience Institute-South Bay, explains that aspirin’s ability to decrease the formation of blood clots also increases the risk of bleeding in the brain. As blood clots play a crucial role in the body’s ability to control bleeding, inhibiting clot formation hampers the body’s ability to manage bleeding once it occurs.
Limitations and Further Research
Though this study sheds light on the effects of low dose aspirin on stroke risk, it does have some limitations. The number of stroke cases and intracranial bleeding instances was relatively low, making the findings susceptible to random and systematic errors. Furthermore, the study specifically focused on primary stroke prevention in healthy older adults without overt cardiovascular disease, excluding those who could potentially benefit the most from low dose aspirin.
Dr. Maria Parekh, a stroke researcher and assistant professor of neurology, emphasizes the importance of considering these limitations. Moreover, she highlights that aspirin has been proven to be beneficial for individuals who have already experienced an ischemic stroke (caused by interrupted or reduced blood supply to the brain) as it helps prevent the formation of blood clots that can trigger subsequent strokes. This scenario is referred to as secondary prevention.
Dr. Ziad Hage, a cerebrovascular and endovascular neurosurgeon, suggests that the findings of this study may not apply to populations with a higher risk of stroke or secondary stroke prevention. Additionally, the predominantly older, white participants in the study, who also had easy access to blood pressure and lipid-lowering medications, may not represent the broader demographic diversity.
Weighing the Risks and Making Informed Decisions
Based on the study findings, it seems that recommending low dose aspirin to healthy individuals with no cardiovascular risk factors may cause more harm than good. In these cases, patients might benefit more from implementing conservative lifestyle modifications, such as maintaining a healthy diet and engaging in regular exercise. It is crucial to avoid prescribing aspirin to patients at higher risk of cardiovascular conditions like stroke, as well as to those with an increased risk of falls unless absolutely necessary.
Dr. Hage emphasizes the importance of seeking medical care immediately when experiencing stroke symptoms, such as sudden weakness in the face, arm, or leg, slurred speech or difficulty speaking, sudden vision loss in one eye, or loss of balance. Consulting with a specialist is paramount in order to determine the most appropriate course of action.
This study serves as a reminder that stroke prevention strategies must be personalized and take individual risk factors into consideration. Further research is needed to provide more comprehensive insights into the effects of low dose aspirin, particularly in diverse populations and in the context of secondary stroke prevention.
